Fructose-1,6-diphosphate fails to limit early myocardial infarction size in a canine model.

STUDY OBJECTIVE Fructose-1,6-diphosphate (FDP) appears to improve early post-myocardial infarction hemodynamics and limit early myocardial infarct size in previous canine studies. However, these studies did not account for the effect of collateral blood flow on infarct size. Our objective was to determine the effect of FDP on early infarct size and hemodynamics while measuring regional myocardial blood flow. DESIGN A prospective, blinded, placebo-controlled laboratory study using a canine open-chest left anterior descending coronary artery (LAD) occlusion model. INTERVENTIONS Twenty-two mongrel dogs were assigned randomly to receive either FDP (175 mg/kg, then 2 mg/kg/min for two hours) or placebo, beginning five minutes after LAD occlusion. MEASUREMENTS AND MAIN RESULTS Regional myocardial blood flow, hemodynamics, and myocardial infarct size were determined. Infarct size was assessed using magnetic resonance imaging in a subset of animals. Three of the 22 dogs had no infarct and significantly higher collateral blood flow than the 19 animals with myocardial infarction (P < .001). Four hours after LAD occlusion, cardiac index, dP/dtmax, heart rate, and systolic and mean aortic pressures were not statistically different between groups. Infarct size expressed as area of necrosis/area at risk was similar between groups (FDP, 0.55 +/- 0.28; controls, 0.59 +/- 0.31). CONCLUSION FDP given after occlusion of the LAD in this canine model did not limit early myocardial infarct size.

[1]  C. Chlouverakis.  The lipolytic action of fructose-1-6-diphosphate. , 1968, Metabolism: clinical and experimental.

[2]  J L Duerk,et al.  Distinguishing viable from infarcted myocardium after experimental ischemia and reperfusion by using nuclear magnetic resonance imaging. , 1990, Journal of the American College of Cardiology.

[3]  G. Heusch,et al.  Measurement of Regional Myocardial Blood Flow With Multiple Colored Microspheres* , 1991, Circulation.

[4]  K. Bailey,et al.  Animal Models for Protecting Ischemic Myocardium: Results of the NHLBI Cooperative Study Comparison of Unconscious and Conscious Dog Models , 1985, Circulation research.

[5]  W. Schaper,et al.  The collateral circulation of the heart. , 1988, Progress in cardiovascular diseases.

[6]  R. Jennings,et al.  Development of cell injury in sustained acute ischemia. , 1990, Circulation.

[7]  M. Fishbein,et al.  Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. , 1981, American heart journal.

[8]  A. Markov,et al.  Hemodynamics and metabolic effects of fructose 1-6 diphosphate in ischemia and shock--experimental and clinical observations. , 1986, Annals of emergency medicine.

[9]  J. Olson,et al.  The effects of fructose-1,6-diphosphate on myocardial damage in acute coronary artery occlusion. , 1991, Resuscitation.

[10]  D Tscholakoff,et al.  MRI of reperfused myocardial infarct in dogs. , 1986, AJR. American journal of roentgenology.

[11]  D Tscholakoff,et al.  Early-phase myocardial infarction: evaluation by MR imaging. , 1986, Radiology.

[12]  A. Markov,et al.  Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia. , 1980, American heart journal.

[13]  P. Pairolero,et al.  Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs. , 1975, The Journal of thoracic and cardiovascular surgery.

[14]  L. Ferrucci,et al.  Improved Exercise Tolerance by IV Fructose‐l,6‐Diphosphate in Chronic, Stable Angina Pectoris , 1988, Journal of clinical pharmacology.

[15]  L. Ferrucci,et al.  Hemodynamic and electrocardiographic effects of fructose-1,6-diphosphate in acute myocardial infarction. , 1985, The American journal of cardiology.

[16]  R. Kloner,et al.  Evaluation of nonradioactive, colored microspheres for measurement of regional myocardial blood flow in dogs. , 1988, Circulation.

[17]  T. Forrester,et al.  Protective effect of exogenous fructose-1,6-diphosphate in cardiogenic shock. , 1988, Cardiovascular research.

[18]  J. Downey,et al.  Lack of a direct metabolic effect of fructose, 1,6-diphosphate in ischemic myocardium. , 1981, The American journal of physiology.

[19]  B. Chance,et al.  Mechanism of the effect of exogenous fructose 1,6-bisphosphate on myocardial energy metabolism. , 1991, Circulation.

[20]  J. Lowe,et al.  Experimental infarct size as a function of the amount of myocardium at risk. , 1978, The American journal of pathology.